ParaSonic

Company Overview

Snapshot

Founded in January 2014 by Mor Cohen, ParaSonic operates with 1–10 employees. The company has raised $4.98M across 4 funding rounds from 5 investors. In May 2019, ParaSonic secured funding from ExitValley.

Business overview

ParaSonic is a Health Tech & Life Sciences company focused on developing medical devices for non-invasive treatments. The company's core product is a home-use ultrasound device designed to eliminate lice and their eggs. This device utilizes short, pulsed ultrasound waves from a wide-toothed comb, augmented by a natural spray, to destroy parasites. ParaSonic targets consumers, particularly parents and children, within the global market, operating in the Medical Treatment & Therapeutics sector.

Strategic signal

In September 2018, news highlighted ParaSonic's innovative approach to tackling head lice, emphasizing the company's homegrown technology. This signals a market validation for non-toxic, high-tech solutions in personal hygiene, indicating investor interest in novel medical devices addressing common health issues.

Company Intelligence Q&A

What is ParaSonic's primary product?

ParaSonic has developed a home-use device that utilizes short, pulsed ultrasound waves and a natural solution to eliminate lice and their eggs in a single combing treatment.

When was ParaSonic founded and by whom?

ParaSonic was founded in January 2014 by Mor Cohen.

What was a key funding event for ParaSonic?

In May 2019, ParaSonic secured funding from ExitValley through an equity crowdfunding round.

What was a notable development for ParaSonic in October 2018?

In October 2018, ParaSonic received funding from 3D Innotech.

What was a significant early investment in ParaSonic?

In April 2015, ParaSonic received seed funding from the Office of the Chief Scientist and NGT3.